Palladium Pd-103

DB15016ExperimentalSmall molecule

Palladium Pd-103 is under investigation in clinical trial NCT00247312 (Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial).

Chemical structure of Palladium Pd-103
Formula / weight
Pd ยท 102.9061 g/mol (avg)
Code names
PD-103

Resolves to

Compound
UNII68QTV136DFCAS14967-68-1
Structure
InChIKeyKDLHZDBZIXYQEI-OIOBTWANSA-NSMILES[103Pd]

Which companies are running trials of Palladium Pd-103, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In